Overview of Dr. Vardhana
Dr. Santosha Vardhana is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 6 years. He is one of 494 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 80 publications and over 500 citings.
Office
505 E 70th St
# Weill
New York, NY 10021Fax+1 212-746-8051
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2014
- New York University School of MedicineClass of 2011
Certifications & Licensure
- NY State Medical License 2013 - 2026
- NJ State Medical License 2018 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- A Study of N-acetylcysteine in Patients With COVID-19 Infection Start of enrollment: 2020 May 01
Publications & Presentations
PubMed
- 67 citationsPhase II biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.Alison J. Moskowitz, Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz
Blood. 2021-10-19 - 62 citationsBispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities.Lorenzo Falchi, Santosha A Vardhana, Gilles A Salles
Blood. 2023-02-02 - 58 citationsSARS-CoV-2 in immunocompromised individuals.Susan DeWolf, Justin C Laracy, Miguel-Angel Perales, Mini Kamboj, Marcel R M van den Brink
Immunity. 2022-10-11
Abstracts/Posters
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaSantosha Vardhana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Santosha Vardhana, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019
Press Mentions
- Eleven Scientists Join World-Renowned Faculty at Gerstner Sloan KetteringJuly 15th, 2021
- COVID-19 More Deadly with Blood Than Solid Cancer: StudyFebruary 16th, 2021
- Shop TalkAugust 25th, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: